Cetuximab is a recombinant human/mouse chimeric IgG1 monoclonal antibody that specifically binds to EGFR on both normal and tumor cells, competitively inhibiting the binding of epidermal growth factor (EGF). The gene discussed is EGF; the disease is neoplasm.